Today on the Daily Dive, we welcome back Colin Bletsky, COO and Director of MustGrow Biologics Corp (CSE: MGRO). Colin joins us today to discuss the company’s recent exclusive agreement with Sumitomo Corporation, the results of its non-exclusive Carnation trials and its economic uses, what distinguishes the company from its competitors, and the sustainability of bio-pesticides.
MustGrow Biologics Corp. is an agriculture biotech company focused on providing natural, science-based biological solutions to replace synthetic chemicals used in high-value crops such as fruit & vegetables. The company uses mustard plant components to deliver high-quality disease, insect pest, and weed control, as well as to apply their technology in the most natural and sustainable way possible to growers, the environment, and customers throughout the world.
FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
